A letter to partners

Dear partner:

Harway Pharma cooperates with all willing partners with an open attitude. We promise to be honest and self-disciplined, treat every partner openly, fairly and justly, and put an end to illegal behaviors such as eating, taking, card and asking.

All partners should operate legally, have the necessary qualifications required by relevant national laws and regulations (such as business license, relevant production/business license qualifications, etc.), and cooperate with Harwaypharma in the principle of honesty, integrity and self-discipline. We welcome all partners who are willing to cooperate with Qilu Pharmaceutical to contact relevant personnel directly. You can click "Contact Us" on the official website to contact the contact personnel of relevant material categories. If anyone has obstructed the cooperation for various reasons, such as soliciting bribes, black-box operation, internal bid winner, deliberately creating difficulties, etc., he can report in the system. For details, he can click the "e-procurement" and "supervision and reporting" button on the official website of Harwaypharma to report according to the contact information, and the company will seriously deal with the information if it is true.

Harwaypharma strictly requires all partners to cooperate in good faith and put an end to dishonest behaviors such as short of weight, shoddy goods and fraud. Put an end to commercial bribery, prevent commercial bribery from damaging and hindering the development of normal commercial cooperation between you and us, and ensure the integrity, integrity and law-abiding of both parties. Once any dishonesty or integrity problems are found, Qilu will blacklist them and stop cooperating, and recover the losses caused to Daohe. For specific requirements, see the annex "Letter of Commitment on Integrity and Self-discipline".

Dear partners, let's work together to create a mutually beneficial, honest, clean, efficient, open and transparent cooperation environment.

  • Tel:0546-5057288
  • E-mail:kjb@harwaypharma.com
  • Back to top